Man Group’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.06M | Buy |
139,044
+90,265
| +185% | +$1.34M | ﹤0.01% | 1209 |
|
2025
Q1 | $874K | Sell |
48,779
-39,462
| -45% | -$707K | ﹤0.01% | 1407 |
|
2024
Q4 | $1.54M | Buy |
88,241
+62,798
| +247% | +$1.09M | ﹤0.01% | 1253 |
|
2024
Q3 | $356K | Sell |
25,443
-73,219
| -74% | -$1.02M | ﹤0.01% | 1601 |
|
2024
Q2 | $811K | Sell |
98,662
-18,939
| -16% | -$156K | ﹤0.01% | 1431 |
|
2024
Q1 | $907K | Buy |
+117,601
| New | +$907K | ﹤0.01% | 1469 |
|
2023
Q2 | – | Hold |
0
| – | -$416K | – | 2178 |
|
2023
Q1 | – | Sell |
-21,300
| Closed | -$448K | – | 1560 |
|
2022
Q4 | $448K | Buy |
21,300
+2,800
| +15% | +$58.9K | ﹤0.01% | 1536 |
|
2022
Q3 | $456K | Buy |
+18,500
| New | +$456K | ﹤0.01% | 1517 |
|
2022
Q2 | – | Sell |
-9,500
| Closed | -$245K | – | 2250 |
|
2022
Q1 | $245K | Buy |
+9,500
| New | +$245K | ﹤0.01% | 1795 |
|
2021
Q1 | – | Sell |
-53,777
| Closed | -$1.47M | – | 1996 |
|
2020
Q4 | $1.47M | Buy |
53,777
+200
| +0.4% | +$5.45K | 0.01% | 1301 |
|
2020
Q3 | $989K | Buy |
53,577
+4,807
| +10% | +$88.7K | ﹤0.01% | 1374 |
|
2020
Q2 | $996K | Sell |
48,770
-7,207
| -13% | -$147K | 0.01% | 1269 |
|
2020
Q1 | $817K | Sell |
55,977
-3,635
| -6% | -$53.1K | 0.01% | 1156 |
|
2019
Q4 | $846K | Hold |
59,612
| – | – | ﹤0.01% | 1514 |
|
2019
Q3 | $691K | Sell |
59,612
-300
| -0.5% | -$3.48K | ﹤0.01% | 1504 |
|
2019
Q2 | $1.2M | Sell |
59,912
-1,633
| -3% | -$32.8K | ﹤0.01% | 1462 |
|
2019
Q1 | $1.39M | Sell |
61,545
-3,067
| -5% | -$69.4K | 0.01% | 1465 |
|
2018
Q4 | $1.46M | Sell |
64,612
-7,130
| -10% | -$161K | 0.01% | 1325 |
|
2018
Q3 | $2.06M | Buy |
71,742
+11,455
| +19% | +$329K | 0.01% | 1397 |
|
2018
Q2 | $1.64M | Buy |
60,287
+7,375
| +14% | +$201K | 0.01% | 1428 |
|
2018
Q1 | $1.18M | Buy |
+52,912
| New | +$1.18M | 0.01% | 1444 |
|